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Dear Editor,  
Major surgery suppresses cellular immunity for several days. However, the 
mechanisms underlying T cell dysfunction remain incompletely understood. Among 
other abnormalities, T cell dysfunction after surgery or trauma includes reduced cell 
surface T cell receptor (TCR) and diminished T lymphocyte proliferation response. 
Because a decreased arginine level may inhibit T cell function leading to increased 
susceptibility to infection after injury, catabolism of arginine by arginase I, an enzyme 
highly expressed in human neutrophils, might be an important mechanism by which 
arginine availability could become limited after major surgery. Reduced CD3f 
expression also hampers cytoplasmic signaling in activating T cells. In this regard, we 
examined the temporal patterns of CD3f expression and arginase activity in patients 
undergoing major surgery, following a prospective, single-center observational study 
with 50 patients scheduled for major colorectal surgery. The protocol was approved by 
the Salamanca University Hospital Medical Ethics Committee, performed in 
accordance with the Declaration of Helsinki, and written consent was obtained from all 
patients included in the study. Table 1 shows the time course of distinct parameters 
measured in the blood of patients after undergoing colorectal cancer surgery in an 
attempt to identify a correlation between the levels of CD3f expression, assessed by 
Western blot analysis following electrophoresis of equally loaded samples of isolated 
peripheral blood lymphocytes in each gel electrophoresis lane, and arginase activity, 
measured in the patient sera as previously described. Data corresponding to CD3f 
expression, arginase activity, total and differential (neutrophils, lymphocytes) leukocyte 
count, platelet count, and fibrinogen level were determined in samples collected 24 h 
before preparation of the patient for surgery (day 0), as well as 24 h (day 1), 48 h (day 
2), and 72 h (day 3) after surgery. As shown in Table 1, we found a significant increase 
in arginase activity between preoperative and 24, 48, and 72 h following surgery that 
was concomitant with a significant decrease in CD3f expression between preoperative 
and 24, 48 and 72 h. We found a negative linear correlation between the levels of 
arginase activity and CD3f expression in the first 24 h post-surgery (r = -0.796; p = 
0.003), whereas the neutrophil count was significantly increased after surgery. To our 
knowledge this is the first study that shows a correlation between arginase activity and 
CD3f level following major surgery. These results may suggest that the increase in 
arginase activity levels, likely from an increase in neutrophil count, detected 24 h after 
surgery might reflect a physiological anti-inflammatory response trying to limit immune 
system-mediated organ damage as a consequence of the systemic inflammatory 
response secondary to surgery. In this regard, it is tempting to suggest that systemic 
inflammatory response after surgery could be accompanied by an anti-inflammatory 
process in which arginase could play a major role. Further studies should be performed 
to establish causality between the above data in an attempt to provide a meaningful 
and statistically valid connection and causal relationship between arginase activity 
increase and CD3f loss to prevent excessive inflammatory response and as a putative 
mediator of septic complications after surgery. 
 
